Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease

Summary

This study will evaluate the therapeutic efficacy and safety of DA-9701 with domperidone in patients with Parkinson's disease

Timeline

Start

2013-05

Primary completion

2016-05

Completion

2016-06

Outcome

Met primary endpoint

paper DA-9701 was not inferior to domperidone in changes of 2-hr GERs before and after the treatment PMID 29705555 ↗

Publications

• Shin CM, Lee YJ, Kim JM, Lee JY, Kim KJ, Choi YJ, Kim N, Lee DH. DA-9701 on gastric motility in patients with Parkinson's disease: A randomized controlled trial. Parkinsonism Relat Disord. 2018 Sep;54:84-89. doi: 10.1016/j.parkreldis.2018.04.018. Epub 2018 Apr 21.

Drugs

Indications